OSR Health OSRH
OTC OSRH
$0.19 -0.01 (-5.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

OSR Health (OSRH) Finished Goods (2024 - 2026)

Updated

OSR Health (OSRH) reported Finished Goods of $175,245 for Q2 2026, down 18.8% from $215,693 a year earlier but up 3.9% from the prior quarter.

Analysis

OSR Health (OSRH) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025, OSR Health posted Finished Goods of $215,971, down 77.3% from FY2024.

  • By year, Finished Goods came in at $949,724 in FY2024.
  • Five-year quarterly Finished Goods spans a low of $168,587 in Q1 2026 and a high of $949,724 in Q4 2024.
  • Year over year, Finished Goods has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $168,587 (Q1 2026), $215,971 (Q4 2025) and $205,089 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 OSR Health 6.51 Mn -1.17 Mn 86,605.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175,245.00
Mar 31, 2026 168,587.00
Dec 31, 2025 215,971.00
Sep 30, 2025 205,089.00
Jun 30, 2025 215,693.00
Mar 31, 2025 764,313.00
Dec 31, 2024 949,724.00
API Access

OSR Health Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=OSRH&period=max&api_key=YOUR_API_KEY